We are extremely honored to have been awarded a $12 Million grant by the Bill & Melinda Gates Foundation to...
Access to the Market. Fast and Safe.
In order to accelerate your access to the market, we have state-of-the-art infrastructures to develop and produce bulks of Active Pharmaceutical Ingredients intended for use in humans.
Once your process is optimized, and during technology transfer, Univercells can supply globally quantities of APIs to support your short term clinical trials (phase 1, 2 & 3) and your long term commercialization.